AestheticsFeatures

Biological Effects of Hyaluronic Acid-Based Dermal Fillers and Laser Therapy on Human Skin Models

By September 23, 2020No Comments

Featured Article

Featured Article

This study investigates the molecular effects of different stabilized HA and poly-l-lactic acid (PLLA)-based fillers with and without subsequent additional fractional laser co-treatment.

Read more

This study investigates the molecular effects of different stabilized HA and poly-l-lactic acid (PLLA)-based fillers with and without subsequent additional fractional laser co-treatment.

Laura Huth PhD, Yvonne Marquardt, Ruth Heise PhD, Katharina Fietkau, Jens Malte Baron MD, Sebastian Huth PhD

 

Injection of hyaluronic acid (HA) dermal fillers is one of the most frequently performed aesthetic procedures. HA fillers exist in many different formulations differing in HA concentration, particle size and cross-linking density.

While HA fillers with high-density and large particles are recommended for deep dermal injections, fillers with low-density and small particles are more commonly used for fine lines.

The direct biological effects of dermal fillers monotherapy and combination therapy with ablative fractional CO2- or Er:YAG laser irradiation on human skin cells are not completely understood. Organotypic three-dimensional (3D) skin equivalents have been established for standardized studies of the human skin.

The aim of the present study was to investigate the molecular effects of different stabilized HA and poly-l-lactic acid (PLLA)-based fillers with and without subsequent additional fractional laser co-treatment.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis

Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Fast itch relief and comparable skin clearance at week 4 - a nonsteroidal option to note for mild-moderate AD In a phase 2, dose‑ranging trial, twice‑daily 1.5% ruxolitinib cream matched…
Journal of Drugs in Dermatology JDD Article About 1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use

1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use

| Atopic Dermatitis, Featured Articles, Latest News, Pediatrics, The Latest | No Comments
A simple 1% colloidal oatmeal regimen cut itch and improved eczema scores within days in toddlers A small open‑label study in children aged 3-72 months tested a twice‑daily 1% colloidal…
Journal of Drugs in Dermatology JDD Article About Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin. Concentrates on skin of color

Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin

| Dyspigmentation, Featured Articles, Latest News, Skin of Color, The Latest | No Comments
A multi-acid, antioxidant delivery approach that promises boost in radiance and texture without PIH.  Worth a look for patients with FST V–VI Facial rejuvenation that's both effective and safe in…

Leave a Reply